APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Complement Protein C5 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Complement Protein C5 Inhibitors Industry Growth and Trends Forecast to 2032

Report ID 173980180128 December 202597 pages

Choose your research edition.

Industry ResearchComplement Protein C5 Inhibitors Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Complement Protein C5 Inhibitors Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Complement Protein C5 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Complement Protein C5 Inhibitors Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Complement Protein C5 Inhibitors Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Complement Protein C5 Inhibitors market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Complement Protein C5 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Complement Protein C5 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Complement Protein C5 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Complement Protein C5 Inhibitors include UCB, Alexion Pharmaceuticals, Astellas Pharma, Regeneron Pharmaceuticals, Amgen, Roche and Samsung Bioepis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Complement Protein C5 Inhibitors market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Complement Protein C5 Inhibitors market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Complement Protein C5 Inhibitors market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Complement Protein C5 Inhibitors.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Complement Protein C5 Inhibitors market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Complement Protein C5 Inhibitors Market by Company

UCB

Alexion Pharmaceuticals

Astellas Pharma

Regeneron Pharmaceuticals

Amgen

Roche

Samsung Bioepis

Complement Protein C5 Inhibitors Segment by Type

Subcutaneous Administration

Oral Administration

Intravenous Injection

Complement Protein C5 Inhibitors Segment by Application

Geographic Atrophy (GA)

Atypical Hemolytic Uremic Syndrome (aHUS)

Neuromyelitis Optica Spectrum Disorde (NMOSD)

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Others

Complement Protein C5 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Complement Protein C5 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Complement Protein C5 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Complement Protein C5 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Complement Protein C5 Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Complement Protein C5 Inhibitors in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Subcutaneous Administration Table 2. Major Company of Oral Administration Table 3. Major Company of Intravenous Injection Table 4. Global Complement Protein C5 Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 6. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Type (2021-2026) Table 7. Global Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 8. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Type (2021-2026) Table 9. Global Complement Protein C5 Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 10. Global Complement Protein C5 Inhibitors Sales by Type (2027-2032) & (K Units) Table 11. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Type (2027-2032) Table 12. Global Complement Protein C5 Inhibitors Sales by Type (2027-2032) & (US$ Million) Table 13. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Type (2027-2032) Table 14. Global Complement Protein C5 Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 15. North America Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 16. North America Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 18. Europe Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 22. Latin America Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Complement Protein C5 Inhibitors Sales by Type (2021-2026) & (US$ Million) Table 25. Complement Protein C5 Inhibitors Industry Trends Table 26. Complement Protein C5 Inhibitors Industry Drivers Table 27. Complement Protein C5 Inhibitors Industry Opportunities and Challenges Table 28. Complement Protein C5 Inhibitors Industry Restraints Table 29. Global Complement Protein C5 Inhibitors Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Complement Protein C5 Inhibitors Revenue Market Share by Company (2021-2026) Table 31. Global Complement Protein C5 Inhibitors Sales by Company (2021-2026) & (K Units) Table 32. Global Complement Protein C5 Inhibitors Sales Share by Company (2021-2026) Table 33. Global Complement Protein C5 Inhibitors Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Complement Protein C5 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Complement Protein C5 Inhibitors Major Company Production Sites and Headquarters Table 36. Global Complement Protein C5 Inhibitors Company, Product Type & Application Table 37. Global Complement Protein C5 Inhibitors Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Complement Protein C5 Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Complement Protein C5 Inhibitors Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Complement Protein C5 Inhibitors Sales by Region (2021-2026) & (K Units) Table 42. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Region (2021-2026) Table 43. Global Complement Protein C5 Inhibitors Sales by Region (2021-2026) & (US$ Million) Table 44. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Region (2021-2026) Table 45. Global Complement Protein C5 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Complement Protein C5 Inhibitors Sales by Region (2027-2032) & (K Units) Table 47. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Region (2027-2032) Table 48. Global Complement Protein C5 Inhibitors Sales by Region (2027-2032) & (US$ Million) Table 49. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Region (2027-2032) Table 50. Global Complement Protein C5 Inhibitors Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Complement Protein C5 Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 53. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Application (2021-2026) Table 54. Global Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 55. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Application (2021-2026) Table 56. Global Complement Protein C5 Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 57. Global Complement Protein C5 Inhibitors Sales by Application (2027-2032) & (K Units) Table 58. Global Complement Protein C5 Inhibitors Sales Market Share in Volume by Application (2027-2032) Table 59. Global Complement Protein C5 Inhibitors Sales by Application (2027-2032) & (US$ Million) Table 60. Global Complement Protein C5 Inhibitors Sales Market Share in Value by Application (2027-2032) Table 61. Global Complement Protein C5 Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 62. North America Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 63. North America Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 65. Europe Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 69. Latin America Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Complement Protein C5 Inhibitors Sales by Application (2021-2026) & (US$ Million) Table 72. UCB Company Information Table 73. UCB Business Overview Table 74. UCB Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. UCB Complement Protein C5 Inhibitors Product Portfolio Table 76. UCB Recent Development Table 77. Alexion Pharmaceuticals Company Information Table 78. Alexion Pharmaceuticals Business Overview Table 79. Alexion Pharmaceuticals Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Alexion Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolio Table 81. Alexion Pharmaceuticals Recent Development Table 82. Astellas Pharma Company Information Table 83. Astellas Pharma Business Overview Table 84. Astellas Pharma Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Astellas Pharma Complement Protein C5 Inhibitors Product Portfolio Table 86. Astellas Pharma Recent Development Table 87. Regeneron Pharmaceuticals Company Information Table 88. Regeneron Pharmaceuticals Business Overview Table 89. Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolio Table 91. Regeneron Pharmaceuticals Recent Development Table 92. Amgen Company Information Table 93. Amgen Business Overview Table 94. Amgen Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Amgen Complement Protein C5 Inhibitors Product Portfolio Table 96. Amgen Recent Development Table 97. Roche Company Information Table 98. Roche Business Overview Table 99. Roche Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Roche Complement Protein C5 Inhibitors Product Portfolio Table 101. Roche Recent Development Table 102. Samsung Bioepis Company Information Table 103. Samsung Bioepis Business Overview Table 104. Samsung Bioepis Complement Protein C5 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Samsung Bioepis Complement Protein C5 Inhibitors Product Portfolio Table 106. Samsung Bioepis Recent Development Table 107. North America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. North America Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units) Table 109. North America Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026) Table 110. North America Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 111. North America Complement Protein C5 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 112. North America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. North America Complement Protein C5 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 114. North America Complement Protein C5 Inhibitors Market Share by Country (2021-2026) Table 115. North America Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. North America Complement Protein C5 Inhibitors Market Share Forecast by Country (2027-2032) Table 117. Europe Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Europe Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units) Table 119. Europe Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026) Table 120. Europe Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 121. Europe Complement Protein C5 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 122. Europe Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Europe Complement Protein C5 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 124. Europe Complement Protein C5 Inhibitors Market Share by Country (2021-2026) Table 125. Europe Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Europe Complement Protein C5 Inhibitors Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units) Table 129. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026) Table 130. Asia-Pacific Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 131. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 132. Asia-Pacific Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Asia-Pacific Complement Protein C5 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 134. Asia-Pacific Complement Protein C5 Inhibitors Market Share by Country (2021-2026) Table 135. Asia-Pacific Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Asia-Pacific Complement Protein C5 Inhibitors Market Share Forecast by Country (2027-2032) Table 137. Latin America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. Latin America Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units) Table 139. Latin America Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026) Table 140. Latin America Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 141. Latin America Complement Protein C5 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 142. Latin America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Latin America Complement Protein C5 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 144. Latin America Complement Protein C5 Inhibitors Market Share by Country (2021-2026) Table 145. Latin America Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Latin America Complement Protein C5 Inhibitors Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Complement Protein C5 Inhibitors Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share by Country (2021-2026) Table 150. Middle East and Africa Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032) & (K Units) Table 151. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share Forecast by Country (2027-2032) Table 152. Middle East and Africa Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Middle East and Africa Complement Protein C5 Inhibitors Market Size by Country (2021-2026) & (US$ Million) Table 154. Middle East and Africa Complement Protein C5 Inhibitors Market Share by Country (2021-2026) Table 155. Middle East and Africa Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Middle East and Africa Complement Protein C5 Inhibitors Market Share Forecast by Country (2027-2032) Table 157. Key Raw Materials Table 158. Raw Materials Key Suppliers Table 159. Complement Protein C5 Inhibitors Distributors List Table 160. Complement Protein C5 Inhibitors Customers List Table 161. Research Programs/Design for This Report Table 162. Authors List of This Report Table 163. Secondary Sources Table 164. Primary Sources List of Figures Figure 1. Complement Protein C5 Inhibitors Image Figure 2. Global Complement Protein C5 Inhibitors Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Complement Protein C5 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 4. Global Complement Protein C5 Inhibitors Sales (2021-2032) & (K Units) Figure 5. Subcutaneous Administration Image Figure 6. Global Subcutaneous Administration Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oral Administration Image Figure 8. Global Oral Administration Sales YoY Growth (2021-2032) & (K Units) Figure 9. Intravenous Injection Image Figure 10. Global Intravenous Injection Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Complement Protein C5 Inhibitors Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Complement Protein C5 Inhibitors Market Share by Type 2025 VS 2032 Figure 13. North America Complement Protein C5 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 14. North America Complement Protein C5 Inhibitors Sales Market Share in Value by Type in 2025 Figure 15. Europe Complement Protein C5 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 16. Europe Complement Protein C5 Inhibitors Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share in Value by Type in 2025 Figure 19. Latin America Complement Protein C5 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Complement Protein C5 Inhibitors Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Complement Protein C5 Inhibitors Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Geographic Atrophy (GA) Image Figure 26. Global Geographic Atrophy (GA) Sales YoY Growth (2021-2032) & (K Units) Figure 27. Atypical Hemolytic Uremic Syndrome (aHUS) Image Figure 28. Global Atypical Hemolytic Uremic Syndrome (aHUS) Sales YoY Growth (2021-2032) & (K Units) Figure 29. Neuromyelitis Optica Spectrum Disorde (NMOSD) Image Figure 30. Global Neuromyelitis Optica Spectrum Disorde (NMOSD) Sales YoY Growth (2021-2032) & (K Units) Figure 31. Paroxysmal Nocturnal Hemoglobinuria (PNH) Image Figure 32. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Complement Protein C5 Inhibitors Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Complement Protein C5 Inhibitors Market Share by Application 2025 VS 2032 Figure 37. North America Complement Protein C5 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 38. North America Complement Protein C5 Inhibitors Sales Market Share in Value by Application in 2025 Figure 39. Europe Complement Protein C5 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 40. Europe Complement Protein C5 Inhibitors Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Complement Protein C5 Inhibitors Sales Market Share in Value by Application in 2025 Figure 43. Latin America Complement Protein C5 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Complement Protein C5 Inhibitors Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Complement Protein C5 Inhibitors Sales Market Share in Value by Application in 2025 Figure 47. North America Complement Protein C5 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Complement Protein C5 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Complement Protein C5 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Complement Protein C5 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Complement Protein C5 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Complement Protein C5 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Complement Protein C5 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Complement Protein C5 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Complement Protein C5 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Complement Protein C5 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Complement Protein C5 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Complement Protein C5 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Complement Protein C5 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Complement Protein C5 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Complement Protein C5 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Complement Protein C5 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Complement Protein C5 Inhibitors Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Complement Protein C5 Inhibitors Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Complement Protein C5 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Complement Protein C5 Inhibitors Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Complement Protein C5 Inhibitors Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Complement Protein C5 Inhibitors Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Subcutaneous Administration
  • Oral Administration
  • Intravenous Injection
Applications
  • Geographic Atrophy (GA)
  • Atypical Hemolytic Uremic Syndrome (aHUS)
  • Neuromyelitis Optica Spectrum Disorde (NMOSD)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Others
Companies covered
  • UCB
  • Alexion Pharmaceuticals
  • Astellas Pharma
  • Regeneron Pharmaceuticals
  • Amgen
  • Roche
  • Samsung Bioepis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Complement Protein C5 Inhibitors Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Complement Protein C5 Inhibitors Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Complement Protein C5 Inhibitors Market by Type
  6. 1.3.1 Subcutaneous Administration
  7. 1.3.2 Oral Administration
  8. 1.3.3 Intravenous Injection
  9. 1.4 Global Complement Protein C5 Inhibitors Market Size by Type
  10. 1.4.1 Global Complement Protein C5 Inhibitors Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Complement Protein C5 Inhibitors Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Complement Protein C5 Inhibitors Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Complement Protein C5 Inhibitors Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Complement Protein C5 Inhibitors Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Complement Protein C5 Inhibitors Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Complement Protein C5 Inhibitors Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Complement Protein C5 Inhibitors Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Complement Protein C5 Inhibitors Industry Trends
  2. 2.2 Complement Protein C5 Inhibitors Industry Drivers
  3. 2.3 Complement Protein C5 Inhibitors Industry Opportunities and Challenges
  4. 2.4 Complement Protein C5 Inhibitors Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Complement Protein C5 Inhibitors Revenue (2021-2026)
  2. 3.2 Global Top Players by Complement Protein C5 Inhibitors Sales (2021-2026)
  3. 3.3 Global Top Players by Complement Protein C5 Inhibitors Price (2021-2026)
  4. 3.4 Global Complement Protein C5 Inhibitors Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Complement Protein C5 Inhibitors Major Company Production Sites & Headquarters
  6. 3.6 Global Complement Protein C5 Inhibitors Company, Product Type & Application
  7. 3.7 Global Complement Protein C5 Inhibitors Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Complement Protein C5 Inhibitors Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Complement Protein C5 Inhibitors Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Complement Protein C5 Inhibitors Tier 1, Tier 2, and Tier 3
4 Complement Protein C5 Inhibitors Regional Status and Outlook
  1. 4.1 Global Complement Protein C5 Inhibitors Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Complement Protein C5 Inhibitors Historic Market Size by Region
  3. 4.2.1 Global Complement Protein C5 Inhibitors Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Complement Protein C5 Inhibitors Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Complement Protein C5 Inhibitors Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Complement Protein C5 Inhibitors Forecasted Market Size by Region
  7. 4.3.1 Global Complement Protein C5 Inhibitors Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Complement Protein C5 Inhibitors Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Complement Protein C5 Inhibitors Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Complement Protein C5 Inhibitors by Application
  1. 5.1 Complement Protein C5 Inhibitors Market by Application
  2. 5.1.1 Geographic Atrophy (GA)
  3. 5.1.2 Atypical Hemolytic Uremic Syndrome (aHUS)
  4. 5.1.3 Neuromyelitis Optica Spectrum Disorde (NMOSD)
  5. 5.1.4 Paroxysmal Nocturnal Hemoglobinuria (PNH)
  6. 5.1.5 Others
  7. 5.2 Global Complement Protein C5 Inhibitors Market Size by Application
  8. 5.2.1 Global Complement Protein C5 Inhibitors Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Complement Protein C5 Inhibitors Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Complement Protein C5 Inhibitors Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Complement Protein C5 Inhibitors Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Complement Protein C5 Inhibitors Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Complement Protein C5 Inhibitors Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Complement Protein C5 Inhibitors Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Complement Protein C5 Inhibitors Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 UCB
  2. 6.1.1 UCB Company Information
  3. 6.1.2 UCB Business Overview
  4. 6.1.3 UCB Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 UCB Complement Protein C5 Inhibitors Product Portfolio
  6. 6.1.5 UCB Recent Developments
  7. 6.2 Alexion Pharmaceuticals
  8. 6.2.1 Alexion Pharmaceuticals Company Information
  9. 6.2.2 Alexion Pharmaceuticals Business Overview
  10. 6.2.3 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Alexion Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolio
  12. 6.2.5 Alexion Pharmaceuticals Recent Developments
  13. 6.3 Astellas Pharma
  14. 6.3.1 Astellas Pharma Company Information
  15. 6.3.2 Astellas Pharma Business Overview
  16. 6.3.3 Astellas Pharma Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Astellas Pharma Complement Protein C5 Inhibitors Product Portfolio
  18. 6.3.5 Astellas Pharma Recent Developments
  19. 6.4 Regeneron Pharmaceuticals
  20. 6.4.1 Regeneron Pharmaceuticals Company Information
  21. 6.4.2 Regeneron Pharmaceuticals Business Overview
  22. 6.4.3 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Regeneron Pharmaceuticals Complement Protein C5 Inhibitors Product Portfolio
  24. 6.4.5 Regeneron Pharmaceuticals Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Complement Protein C5 Inhibitors Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Roche
  32. 6.6.1 Roche Company Information
  33. 6.6.2 Roche Business Overview
  34. 6.6.3 Roche Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Roche Complement Protein C5 Inhibitors Product Portfolio
  36. 6.6.5 Roche Recent Developments
  37. 6.7 Samsung Bioepis
  38. 6.7.1 Samsung Bioepis Company Information
  39. 6.7.2 Samsung Bioepis Business Overview
  40. 6.7.3 Samsung Bioepis Complement Protein C5 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Samsung Bioepis Complement Protein C5 Inhibitors Product Portfolio
  42. 6.7.5 Samsung Bioepis Recent Developments
7 North America by Country
  1. 7.1 North America Complement Protein C5 Inhibitors Sales by Country
  2. 7.1.1 North America Complement Protein C5 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  4. 7.1.3 North America Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032)
  5. 7.2 North America Complement Protein C5 Inhibitors Market Size by Country
  6. 7.2.1 North America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Complement Protein C5 Inhibitors Market Size by Country (2021-2026)
  8. 7.2.3 North America Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Complement Protein C5 Inhibitors Sales by Country
  2. 8.1.1 Europe Complement Protein C5 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  4. 8.1.3 Europe Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Complement Protein C5 Inhibitors Market Size by Country
  6. 8.2.1 Europe Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Complement Protein C5 Inhibitors Market Size by Country (2021-2026)
  8. 8.2.3 Europe Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Complement Protein C5 Inhibitors Sales by Country
  2. 9.1.1 Asia-Pacific Complement Protein C5 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Complement Protein C5 Inhibitors Market Size by Country
  6. 9.2.1 Asia-Pacific Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Complement Protein C5 Inhibitors Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Complement Protein C5 Inhibitors Sales by Country
  2. 10.1.1 South America Complement Protein C5 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  4. 10.1.3 South America Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032)
  5. 10.2 South America Complement Protein C5 Inhibitors Market Size by Country
  6. 10.2.1 South America Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Complement Protein C5 Inhibitors Market Size by Country (2021-2026)
  8. 10.2.3 South America Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Complement Protein C5 Inhibitors Sales by Country
  2. 11.1.1 Middle East and Africa Complement Protein C5 Inhibitors Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Complement Protein C5 Inhibitors Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Complement Protein C5 Inhibitors Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Complement Protein C5 Inhibitors Market Size by Country
  6. 11.2.1 Middle East and Africa Complement Protein C5 Inhibitors Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Complement Protein C5 Inhibitors Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Complement Protein C5 Inhibitors Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Complement Protein C5 Inhibitors Value Chain Analysis
  2. 12.1.1 Complement Protein C5 Inhibitors Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Complement Protein C5 Inhibitors Production Mode & Process
  7. 12.2 Complement Protein C5 Inhibitors Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Complement Protein C5 Inhibitors Distributors
  10. 12.2.3 Complement Protein C5 Inhibitors Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst